A carregar...
Are cystic fibrosis mutation carriers a potentially highly vulnerable group to COVID‐19?
Undoubtedly, the new SARS‐CoV‐2 virus poses a grave health threat, plaguing the health and socio‐economic sectors. COVID‐19 disease must be treated quickly and effectively as soon as possible. The main axes in this direction are establishing vaccines, drugs, diagnostic tests, as well as identifying...
Na minha lista:
| Publicado no: | J Cell Mol Med |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7675715/ https://ncbi.nlm.nih.gov/pubmed/33009727 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jcmm.15941 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|